Zobrazeno 1 - 10
of 13
pro vyhledávání: '"C. D. Mitnick"'
Autor:
S. B. Patil, M. Tamirat, K. Khazhidinov, E. Ardizzoni, M. Atger, A. Austin, E. Baudin, M. Bekhit, S. Bektasov, E. Berikova, M. Bonnet, R. Caboclo, M. Chaudhry, V. Chavan, S. Cloez, J. Coit, S. Coutisson, Z. Dakenova, B. C. De Jong, C. Delifer, S. Demaisons, J. M. Do, D. Dos Santos Tozzi, V. Ducher, G. Ferlazzo, M. Gouillou, U. Khan, M. Kunda, N. Lachenal, A. N. LaHood, L. Lecca, M. Mazmanian, H. McIlleron, M. Moreau, M. Moschioni, P. Nahid, E. Osso, L. Oyewusi, S. Panda, A. Pâquet, P. Thuong Huu, L. Pichon, M. L. Rich, P. Rupasinghe, N. Salahuddin, E. Sanchez Garavito, K. J. Seung, G. E. Velásquez, M. Vallet, F. Varaine, F. J. Yuya-Septoh, C. D. Mitnick, L. Guglielmetti
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-14 (2023)
Abstract Background Treatment for fluoroquinolone-resistant multidrug-resistant/rifampicin-resistant tuberculosis (pre-XDR TB) often lasts longer than treatment for less resistant strains, yields worse efficacy results, and causes substantial toxicit
Externí odkaz:
https://doaj.org/article/2bb066dc17d74fc58700a32bcf0b5485
Autor:
L. Guglielmetti, E. Ardizzoni, M. Atger, E. Baudin, E. Berikova, M. Bonnet, E. Chang, S. Cloez, J. M. Coit, V. Cox, B. C. de Jong, C. Delifer, J. M. Do, D. Dos Santos Tozzi, V. Ducher, G. Ferlazzo, M. Gouillou, A. Khan, U. Khan, N. Lachenal, A. N. LaHood, L. Lecca, M. Mazmanian, H. McIlleron, M. Moschioni, K. O’Brien, O. Okunbor, L. Oyewusi, S. Panda, S. B. Patil, P. P. J. Phillips, L. Pichon, P. Rupasinghe, M. L. Rich, N. Saluhuddin, K. J. Seung, M. Tamirat, L. Trippa, M. Cellamare, G. E. Velásquez, S. Wasserman, P. J. Zimetbaum, F. Varaine, C. D. Mitnick
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-15 (2021)
Abstract Background Treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR-TB) is expensive, labour-intensive, and associated with substantial adverse events and poor outcomes. While most MDR/RR-TB patients do not receive treatment, many
Externí odkaz:
https://doaj.org/article/85bd589a0cd64486abc5fda915c2f7c5
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/d110f51466494be29eab3afe14add0b7
Autor:
M. L. Rich, U. Khan, C. Zeng, A. LaHood, M. F. Franke, S. Atwood, M. Bastard, E. Burhan, N. Danielyan, P. M. Dzhazibekova, D. Gadissa, A. Ghafoor, C. Hewison, M. S. Islam, E. Kazmi, P. Y. Khan, L. Lecca, L. B. Maama, N. Melikyan, Y. Y. Naing, K. Philippe, N. A. Saki, K. J. Seung, A. Skrahina, G. B. Tefera, F. Varaine, S. C. Vilbrun, L. Võ, C. D. Mitnick, H. Huerga, null on behalf of the endTB Observational Study Te
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 27:451-457
BACKGROUND: Evidence of the effectiveness of the WHO-recommended design of longer individualized regimens for multidrug- or rifampicin-resistant TB (MDR/RR-TB) is limited.OBJECTIVES: To report end-of-treatment outcomes for MDR/RR-TB patients from a 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1643b18bb1ecee1c25d380c3416b7f5
https://doi.org/10.5588/ijtld.22.0613
https://doi.org/10.5588/ijtld.22.0613
Autor:
C. Zeng, C. D. Mitnick, C. Hewison, M. Bastard, P. Khan, K. J. Seung, M. L. Rich, S. Atwood, N. Melikyan, N. Morchiladze, N. Khachatryan, M. Khmyz, C. G. Restrepo, N. Salahuddin, E. Kazmi, A. A. Dahri, S. Ahmed, F. Varaine, S. C. Vilbrun, L. Oyewusi, A. Gelin, K. Tintaya, L. T. Yeraliyeva, S. Hamid, U. Khan, H. Huerga, M. F. Franke
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 27:34-40
BACKGROUND: The WHO provides standardized outcome definitions for rifampicin-resistant (RR) and multidrug-resistant (MDR) TB. However, operationalizing these definitions can be challenging in some clinical settings, and incorrect classification may g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e0373292e73af99f67788eb62a3bc07
https://doi.org/10.5588/ijtld.22.0324
https://doi.org/10.5588/ijtld.22.0324
Autor:
C. Tzelios, C. Contreras, B. Istenes, A. Astupillo, L. Lecca, K. Ramos, L. Ramos, K. Roca, J. T. Galea, M. Tovar, C. D. Mitnick, J. Peinado
Publikováno v:
Public Health Action
Chatbots have emerged as a first link to care in recent years. The COVID-19 pandemic, and consequent health system disruptions, expanded their use. Socios En Salud (SES) introduced chatbots in Peru, which experienced one of the highest excess COVID m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcedda9cb72f1c220e1234fc2323e448
https://pubmed.ncbi.nlm.nih.gov/36561900
https://pubmed.ncbi.nlm.nih.gov/36561900
Autor:
A, Schwalb, R, Cachay, A, Wright, P P J, Phillips, P, Kaur, A H, Diacon, C, Ugarte-Gil, C D, Mitnick, T R, Sterling, E, Gotuzzo, C R, Horsburgh
SETTING: Multidrug-resistant TB (MDR-TB) clinical trial in Lima, Peru and Cape Town, South Africa.OBJECTIVE: To identify baseline factors associated with screening failure and study withdrawal in an MDR-TB clinical trial.DESIGN: We screened patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f065037fb79eefe1d6713379408a06
https://hdl.handle.net/20.500.12866/12583
https://hdl.handle.net/20.500.12866/12583
Autor:
C D Mitnick
Publikováno v:
Pneumologie. 71:432-433
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82fd4f75078c6a774bb58d13b5b2bd9b
https://doi.org/10.1055/s-0043-100040
https://doi.org/10.1055/s-0043-100040
Autor:
M L, Rich, A R, Socci, C D, Mitnick, E A, Nardell, M C, Becerra, C, Bonilla, J, Bayona, K J, Seung, J, Furin, P E, Farmer, J S, Mukherjee
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 10(3)
There is no gold standard on how national tuberculosis programs should design retreatment regimens. Often drug susceptibility testing (DST) is not available for all patients, and representative DST patterns in patient populations are used to guide th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb6a38ce06703b1369adfef59013975a
https://pubmed.ncbi.nlm.nih.gov/16562709
https://pubmed.ncbi.nlm.nih.gov/16562709
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 8(3)
National Masan Tuberculosis Hospital, Masan, South Korea, a 430-bed tertiary referral hospital specializing in tuberculosis.To evaluate the treatment outcomes of standardized, empiric regimens for multidrug-resistant tuberculosis (MDR-TB).A retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c520d9a3dcbabd369d5c2667d1487741
https://pubmed.ncbi.nlm.nih.gov/15139476
https://pubmed.ncbi.nlm.nih.gov/15139476